Skip to main content
. 2011 Jun 8;3(6):37. doi: 10.1186/gm253

Table 2.

FDA-approved biomarkers

Organ Sample Proposed mechanism Biomarker References
Heart Blood (PBMCs, mRNA) Gene-expression-based diagnostic score distinguishes stable from acute heart allograft rejection patients and mild from severe AR AlloMap
(11-gene panel)
[92,93]
Heart, liver, lung, kidney Serum (protein) T-cell activation status indicates risk of AR, under-/over-immunosuppression ImmuKnow (T-cell-stimulation-dependent iATP levels) [18,97-100]